UnknownPhase 3NCT03806426

Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis

Studying Familial adenomatous polyposis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
S.L.A. Pharma AG
Principal Investigator
Luigi Ricciardiello, MD, D.M.D
Associate Professor of Gastroenterology, University of Bologna
Intervention
Eicosapentaenoic acid free fatty acid (EPA-FFA)(drug)
Enrollment
204 enrolled
Eligibility
18-65 years · All sexes
Timeline
20182024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03806426 on ClinicalTrials.gov

Other trials for Familial adenomatous polyposis

Additional recruiting or active studies for the same condition.

See all trials for Familial adenomatous polyposis

← Back to all trials